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Abstract
Introduction. Every year, 60.000 people have stroke incidents in Poland. Despite the fact that it can be prevented, 
stroke remains the leading cause of morbidity and mortality worldwide. Hypertension is one of the leading risk 
factors for the stroke incident. The aim was to assess the relationship between inflammatory markers and clinical 
status of hypertensive patients with the stroke.
Material and methods. 713 patients with stroke in the course of hypertension from the Departments of Neurol-
ogy in Bytom and Zabrze were enrolled in the retrospective study. They were divided into groups: N1, R1 (with 
improvement in NIHSS and Rankin results, respectively) and N2, R2 (with deterioration or no changes in NIHSS 
and Rankin between the day of admission and discharge).
Results. The majority of patients were females [%] (51.5 vs 48.5). Women were significantly older than man [years] 
(78.0 vs 69.0, P = 0.001, respectively) and had higher NIHSS results at admission [points] (6.0 vs 5.0, P = 0.001, re-
spectively). There were significant differences in the serum CRP [mg/l] (4.75 vs 9.40, P = 0.001) and WBC [103/µL] 
(8.58 vs 9.02, P = 0.006) between N1 and N2, respectively and between R1 and R2: WBC (8.50 vs 9.00, P = 0.006) 
and CRP (4.20 vs 8.70, P = 0.001), respectively. A significant correlation between CRP and NIHSS on admission 
was observed (R = 0.191, P < 0.05). NIHSS and Rankin score on admission were correlated with age (R = 0.212, and 
R = 0.231, P < 0.05, respectively). CRP was related with the volume [cm3] of lesions in CT (R = 0.170, P < 0.05).
Conclusions. Inflammation seems to be associated with the worse neurological status of patients with stroke and 
hypertension. Age and sex affect the clinical course of stroke. CRP may indicate the size of changes in CT.
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Introduction
Stroke, in its classic definition, is interpreted as 
a neurological deficit caused by an acute focal dam-
age of the central nervous system and is one of the 
leading causes of disability and mortality world-
wide [1].
In 2005, the incidence of stroke was estimated at 
16 million worldwide, predicting that in 2030 this 
figure would increase to 23 million [2]. In 2013 in 
the United States stroke was the fifth leading cause 
of death. Despite declining mortality, nearly 800 000 
people per year experience a new or recurrent stroke, 
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and about 140,000 of stroke victims die [3]. Due to 
the widespread access to a specialist treatment and 
improved medical standards in developed countries, 
the survival rate of stroke victims should increase.
According to researchers, stroke remains the lead-
ing preventable cause of morbidity and mortality 
worldwide, and it can be prevented by e.g. lifestyle 
modification, pharmacological treatment of hyper-
tension, hypercholesterolemia or atrial fibrillation 
(AF)  [4]. It is worth emphasizing that hypertension 
substantially increases the risk of stroke, accounting 
for as much as 52% of cases [5].
In order to determine the degree of neurological 
deficits after stroke, and to predict the outcome, 
specific scales were created, such as the National In-
stitute of Health Stroke Scale (NIHSS), the modified 
Rankin scale (mRS) and Barthel index (BI) [6].
The aim of our study was to assess the associa-
tion between sex, age and the severity of stroke in 
patients with hypertension. Specifically, the study 
aimed to evaluate the inflammatory markers and the 
CT-assessed lesions volume on the clinical outcome 
of patients. 
Material and methods
Our study is a retrospective analysis of medical re-
cords from two referral centers located in Upper 
Silesia region, Poland. Initially, we analyzed the re-
cords of 1000 patients hospitalized between 2013 
and 2016 who were diagnosed with cerebrovascu-
lar diseases from the Departments of Neurology in 
Bytom, and Zabrze. All patients were treated for 
primary hypertension, diagnosed according to the 
European Societies of Hypertension and Cardiology 
Guidelines (2013) [7, 8]. 
The inclusion criteria were as follows: age > 35 
years, inhabitancy of the Upper Silesia region, diag-
nosis of stroke based on the World Health Organiza-
tion (WHO) definition, primary hypertension prior 
to stroke or TIA, ongoing antihypertensive thera-
py. The exclusion criteria were as follows: secondary 
stroke caused by trauma, brain tumor or brain me-
tastases, persistent migraine aura without infarction, 
Todd’s paresis and signs of infection.
Based on patients’ medical history, 713 patients 
met primary inclusion criterion; 661 were diagnosed 
with ischemic stroke, 50 with hemorrhagic stroke 
and 2 with a transient ischemic attack (TIA). 
211 patients were excluded because they were not 
diagnosed with primary hypertension prior to admis-
sion. Another 49 patients admitted that they did not 
take medications against hypertension,15 were found 
to suffer from upper respiratory infection before ad-
mission, 6 had a secondary stroke caused by trauma, 
3 were suspected of brain tumor, 2 were diagnosed 
with persistent migraine aura without infarction and 
1 had documented Todd’s paresis.
Clinical state of the patients was evaluated upon 
admission before the treatment was introduced. The 
patients’ data were re-evaluated at discharge using 
the NIHSS and RANKIN scales. Similarly, the 
CT-based size of stroke lesion and the change of its 
volume [cm3] were analyzed in two corresponding 
timepoints: at baseline (CT1), and at discharge (CT2). 
As the study design was retrospective based on the 
analyses of available clinical data, no Ethical Com-
mittee Board approval was mandatory, as regulated 
by the rules and regulations of our Center.
Statistical analysis
Continuous variables were presented as the median 
and an interquartile range (IQR). The categorical 
variables data were presented as percentages. The 
groups were compared using the nonparametric 
Mann-Whitney U test. The analysis of correlations 
between variables was conducted using the Spear-
man rank correlation analysis. Statistical significance 
was defined as P < 0.05. Statistical analyses were 
performed using the software Statistica 13 (Statsoft, 
Tulsa, Oklahoma, USA).
Results
The median age in the whole study group was 75.0 
years [65.0–81.0]. 358 (50.21%) of the partici-
pants were females and 355 (49.79%) were males. 
Women and men significantly differed in age. The 
median age was 78.00 [70.00–83.00] and 69.00 
[63.00–78.00], P < 0.001 for females and males, 
respectively. The comparison of the clinical data 
with respect to sex was presented in Table I. Fe-
males and males had significantly different per-
centage of patients with stenosis of cervical arteries, 
myocardial infarction and AF. They also differed in 
NIHSS score, Rankin score but they did not differ 
in the volume of stroke lesion in CT. In general, 
patients had from 1 to 4 stroke lesions detected in 
CT, however, the majority, of them (93.04%) had 
1 lesion.
The study group was divided depending on the 
NIHSS and RANKIN results on the day of ad-
mission and discharge into groups: patients with 
improvement in NIHSS (N1; n = 487), with dete-
rioration or no change in NIHSS or patients who 
were found dead (N2; n = 225), with improvement 
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Table I. The comparison of the clinical state in the whole study group divided according to sex
Issue Female (n = 358) Male (n = 355) P
Stenosis of cervical arteries (%) 25.42 38.31 < 0.001
Myocardial infarction (%) 29.61 39.72 0.005
Atrial fibrillation recognized prior to stroke (%) 29.05 18.31 0.001
Atrial fibrillation present during hospitalization (%) 34.64 23.45 0.001
NIHSS on admission 6.00 [3.00–12.00] 5.00 [3.00–8.00] < 0.001
NIHSS at discharge 3.00 [2.00–10.00]
n = 308*
3.00 [1.00–5.00]
n = 317*
0.001
Rankin on admission 4.00 [3.00–5.00] 4.00 [3.00–4.00] < 0.001
Rankin at discharge 3.00 [2.00–5.00]
n = 306*
2.00 [1.00–4.00]
n = 317*
< 0.001
The sum of the volume of all lesions in CT1 [cm3] 3.50 [1.60–12.56] 4.00 [1.82–12.00] 0.79
The sum of the volume of all lesions in CT2 [cm3] 3.35 [1.70–11.22] 2.80 [1.40–12.00] 0.23
*In the rest of cases death was found; the sum of the volume of all lesions in patient in CT1 was 3.85 [1.70–12.00] cm3 and in the CT2 at the end of hospitalization was 3.00 [1.50–11.90] cm3. The greatest lesion in CT1 
was 3.50 [1.70–10.08] cm3 and in the CT2 was 3.00 [1.5–11.25] cm3. In 50.70% [72*] of patients between CT1 and CT2 the whole volume of all lesions remained unchanged. In 28.17% [40*] it has increased and in 
21.13% it has decreased. Patients included in the study were treated with: Loop Diuretics, Aldosterone Antagonists, Thiazides, Thiazide-like Diuretics, ACE Inhibitors, ARBs, Beta-Blockers and Calcium Channel Blockers
CT1 — computed tomography on admission; CT2 — computed tomography at discharge; NIHSS — National Institutes of Health Stroke Scale
Table II. Baseline characteristics of the study groups divided according to the assessment of the clinical status in National Institutes of 
Health Stroke Scale
NIHSS improvement (n = 487) NIHSS deterioration (n = 225) P
Age (years) 73.00 [64.00–80.00] 77.00 [68.00–83.00] < 0.001
Sex (male) (%) 51.54 46–67 0.23
NIHSS on admission 5.00 [3.00–9.00] 5.00 [2.00–23.00] 0.72
NIHSS at discharge 2.00 [1.00–4.00] 3.00 [2.00–8.00]
n = 138**
 < 0.001
Rankin on admission 4.00 [3.00–4.00] 4.00 [2.00–5.00] 0.56
Rankin at discharge 2.00 [1.00–3.00]
n = 485*
3.00 [2.00–4.00]
n = 138**
< 0.001
Improvement in Rankin [%] 76.18
n = 486*
6.22 < 0.001
*the data from the rest of patients were not achievable; **in the rest of cases death was found
NIHSS — National Institutes of Health Stroke Scale
in RANKIN (R1; n = 385) and with deterioration 
or no change in RANKIN or patients who decreased 
(R2; n = 327). 
The study groups N1 and N2 had significantly 
different age, NIHSS score at discharge and Rankin 
score at discharge. The baseline characteristics of 
the study groups were presented in Table II. These 
study groups significantly differ in percentage of 
patients with stenosis of cervical arteries. There were 
also significant differences in the results of C-Re-
active Protein (CRP [mg/l]; 4.75 [1.93–13.65] vs. 
9.40 [2.08–41.72], P = 0.001) and White Blood 
Cells (WBC [103/µL]; 8.58 [7.15–10.40] and 9.02 
[7.28–12.04], P = 0.006) between N1 and N2 
respectively. The comparison of comorbidities be-
tween these groups was presented in Table III. The 
volume of stroke lesion in CT was significantly 
greater in N2. The results in CT were shown in 
Table IV.
The baseline characteristics of the study groups R1 
and R2 were presented in Table V. There were signif-
icant differences in age, NIHSS score on admission 
and at discharge and Rankin score at discharge. The 
comparison in comorbidities between these groups 
was shown in the Table VI. These groups significant-
ly differed in percentage of patients with stenosis of 
cervical arteries. There were significant differences 
in WBC (8.50 [6.99–10.39] vs. 9.00 [7.29–11.46], 
p = 0.006) and CRP (4.20 [1.80–10.87] vs. 8.70 
[2.09–37.70], p = 0.000) between R1 and R2 re-
spectively. The volume of stroke lesion in CT was 
significantly greater in R2 (Table VII).
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Table III. Comorbidities in the study groups divided according to the assessment of the clinical status in National Institutes of Health Stro-
ke Scale
Comorbidities N1 (n = 487) N2 (n = 225) P
Ischemic stroke (%) 94.66 88.89 0.22
Carotid artery stenosis (%) 34.91 25.33 0.01
Thrombolysis (%) 10.72
n = 485*
8.44 0.63
Myocardial infarction (%) 33.47 36.89 0.37
Diabetes type 2 (%) 40.95
n = 486*
41.78 0.86
Obesity (%) 4.72 5.33 0.90
Smoking (%) 5.75 6.67 0.84
*the data from the rest of patients were not available
Table IV. The results in computed tomography in the study groups divided according to the assessment of the results in National Institutes 
of Health Stroke Scale
NIHSS improvement (n = 487) NIHSS deterioration (n = 225) P
The sum of the volume of all lesions in CT1 [cm3] 2.80 [1.60–8.00]
n = 181*
6.00 [2.65–19.85]
n = 88*
0.001
The sum of the volume of all lesions in CT2 [cm3] 2.60 [1.40–7.00]
n = 251*
6.24 [2.08–26.88]
n = 103*
< 0.001
The difference of the volume of lesions between 
CT1 and CT2 [cm3]
0.00 [0.00–0.00]
n = 107*
[0.00–4.50]
n = 35*
0.03
The greatest lesion in CT 1 [cm3] 2.70 [1.60–7.00]
n = 181*
5.67 [2.65–17.50]
n = 88*
0.001
The greatest lesion in CT 2 [cm3] 2.50 [1.26–6.00]
n = 251*
6.00 [2.08–23.68]
n = 103*
< 0.001
*the data from the rest of patients were not available 
CT1 — computed tomography on admission; CT2 — computed tomography at discharge
Table V. Baseline characteristics of the study groups divided according to the results in Rankin scale
R1 (n = 385) R2 (n = 327) P
Age (years) 73.00 [64.00–80] 77.00 [68.00–83.00] < 0.001
Sex (male) (%) 52.99 46.48 0.084
NIHSS on admission 5.00 [3.00–8.00] 6.00 [3.00–13.00] 0.02
NIHSS at discharge 2.00 [1.00–3.00] 4.00 [2.00–8.00]
n = 240**
< 0.001
Improvement in NIHSS (%) 96.36 35.47 < 0.001
Rankin on admission 4.00 [3.00–4.00] 4.00 [3.00–5.00] 0.83
Rankin at discharge 2.00 [1.00–3.00]
n = 384*
3.00 [2.00–5.00]
n = 239**
< 0.001
*the data from the rest of patients were not achievable; **in the rest of cases death was found 
R1 — patients with improvement in Rankin; R2 — patients with no change in Rankin, with deterioration and patients who was found death; NIHSS — National Institutes of Health Stroke Scale
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Table VI. Comorbidities in the study groups divided according to the assessment of the results in Rankin scale
Comorbidities R1 (n = 385) R2 (n = 327) P
Ischemic stroke (%) 94.55 90.83 0.055
Carotid artery stenosis (%) 35.06 28.13 0.05
Thrombolysis (%) 11.49
n = 383*
8.26 0.15
Myocardial infarction (%) 33.77 35.47 0.63
Type 2 diabetes (%) 38.80
n = 384*
44.04 0.16
Obesity (%) 4.16 5.81 0.31
Smoking (%) 4.68 7.65 0.10
*the data from the rest of patients were not achievable 
R1 — patients with improvement in Rankin; R2 — patients with no change in Rankin, with deterioration and patients who was found death
Table VII. The results in computed tomography in the study groups divided according to assessment of the results in Rankin scale
Rankin improved (n = 385) Rankin deteriorated (n = 327) P
The sum of the volume of all lesions in CT1 [cm3] 2.75 [1.60–6.60]
n = 134*
5.46 [1.84–16.42]
n = 135*
< 0.01
The sum of the volume of all lesions in CT2 [cm3] 2.45 [1.20–5.48]
n = 198*
6.04 [2.00–26.12]
n = 156*
< 0.001
The difference of the volume of lesions between 
CT1 and CT2 [cm3]
[0.00–0.00]
n = 81*
0.00 [0.00–2.40]
n = 61*
0.09
The greatest lesion in CT 1 [cm3] 2.75 [1.60–6.00]
n = 134*
5.00 [1.80–16.42]
n = 135*
0.01
The greatest lesion in CT 2 [cm3] 2.30 [1.20–5.00]
n = 198*
6.00 [2.00–24.28]
n = 156*
< 0.001
*the data from the rest of patients were not available 
CT1 — computed tomography on admission; CT2 — computed tomography at discharge; R1 — patients with improvement in Rankin; R2 — patients with no change in Rankin, with deterioration and patients who 
decreased
The state and clinical course of the patients according 
to their age was analyzed. The NIHSS score on admis-
sion correlated with age (R = 0.212, P < 0.05) (Figure 1).
A significant correlation was observed between 
RANKIN on admission and age of participants 
(R = 0.231, P < 0.05).
The results of laboratory tests of the whole group 
of patients with hypertension treated before stroke 
were evaluated. 51.97% of patients had CRP above 
the normal limit and 33.23% of patients had WBC 
above the normal range. The relation between the 
results in clinical scales and CT and values in labora-
tory tests was analyzed. A significant correlation be-
tween CRP and NIHSS on admission was observed 
(R = 0.191, P < 0.05).
The sum of the volume of all lesions in CT2 was 
related to CRP (R = 0.17, P < 0.05).
Discussion
The epidemiological records show that in 2005– 
–2008 almost one-third of adults in the US suffered 
from hypertension, and less than a half of them 
had it sufficiently controlled. This may be associat-
ed with an increased mortality and complications 
rates including myocardial ischemia, strokes, heart 
failure or chronic kidney disease: all of which esca-
lates public health system costs, up to $131 billion 
annually [9].
The long period, prior to the hypertension com-
plications development facilitates unfavourable 
structural and functional cerebral changes i.e.: vessels 
remodelling, blood-brain barrier integration, diffuse 
white matter damage, and also changes in the cerebral 
circulation, including vasodilatation, development of 
inflammation and oxidative stress or a dysfunction of 
the baroreceptor reflex [10]. Persistent elevated blood 
pressure has a considerable impact on the structure 
of brain arteries, triggering adaptive changes such as 
hypertrophy and remodeling [11]. Altogether, these 
mechanisms may contribute to the incident stroke.
Given the fact, that ischemic stroke affects also 
treated hypertensive patients (with more than 1 
blood-lowering drug) [12], suggesting that effective 
treatment only reduces the risk.
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Figure 1. Presentation of the median and interquartile range for the age of patients
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In our analysis, we found that women, experience 
stroke at the older age than men. The study of Hol-
royd-Leduc et al. conducted in a group of 44,832 
patients with an acute stroke also indicated that men 
were younger than women [13]. This is in line with 
the results of other reports [14–16].
Interestingly, we have also found that the cardio-
vascular comorbidities incl. stenosis of the carotid 
arteries, myocardial infarction and AF are more com-
mon in women than in men. Niewada et al. findings 
indicating that in women AF more often coexists and 
the stroke is mainly caused by the embolic events 
(twice as often as in men) [15].
Part of these differences may be ascribed to sexual 
diversity and the influence of sex hormones may 
not be disregarded. The estradiol dilates vessels and 
increases the blood flow, while testosterone has the 
opposite effect, estrogens also have a positive influ-
ence on cerebrovascular reactivity and has anti-in-
flammatory properties [17]. Therefore, women after 
menopause, are actually deprived of this protective 
factor due to the lowering of the estrogens level.
Women with a stroke incident were more often 
admitted with a higher NIHSS score than men and 
at discharge in the Rankin assessment woman were 
worse than man. A study by Santalucia et al. con-
ducted in 1272 stroke patients also showed, that 
the NIHSS result on admission was significantly 
worse in women, at discharge they were more often 
seriously neurologically impaired and the functional 
results in the mRS at discharge were also worse in 
comparison with man [16]. This is not completely 
understood, although one my hypothesize that older 
women are more often widows, socially isolated and 
lonely living and it’s also suggested that women with 
an acute stroke more often than men show diffuse 
and non-specific symptoms, such as confusion, weak-
ness, fatigue or consciousness changes. At admission 
women, more often present symptoms of aphasia, 
dysphagia and visual impairment [14–17].
The analyses indicate that both the NIHSS and 
Rankin results at admission are correlated with age. It 
is estimated that increase by, both in age and baseline 
NIHSS increase the chances for poor outcome in 
stroke survivors by 1.113 and 1.557 times, respec-
tively [18].
Our study also has revealed that patients who 
showed improvement in NIHSS had significantly 
lower CRP levels, and WBC counts than patients 
who had no improvement in NIHSS upon discharge. 
The study of den Hertog et al. which evaluated the 
value of CRP in the very early stages of stroke — in 
the group of patients with ≥ 7 mg/L the NIHSS score 
upon admission was greater and they more often had 
AF which translated to cardioembolic strokes [19]. 
Similar results were observed by other groups [20]. 
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VanGilder et al. demonstrated a positive correlation 
between an acute CRP increase with a long-term 
unfavourable outcome, assessed using NIHSS and 
mRS [21]. It is emphasized that an acute ischemic 
stroke may cause an increase in CRP levels depict-
ing inflammatory response. This phenomenon, when 
present may be a poor predictor suggesting extensive 
tissue damage or co-existing infection additionally, 
it may correlate with the severity of stroke [19, 20]. 
Similar results are also characteristic for the number 
of WBC, the level of which also increases in the 
course of acute stroke [19].
It is also important to emphasize that in a group of 
patients with no improvement or with deterioration 
in NIHSS and Rankin the volume of stroke lesion 
was greater than in patients with better results. The 
study of Yaghi et al. on 510 DWI positive patients 
revealed a graded relationship between the NIHSS 
result and median DWI lesion volume, what proves 
that people with minor stroke symptoms have rel-
atively small brain infarcts documented in imaging 
studies [22]. It is worth to emphasize that despite 
no improvement in the size of stroke lesions during 
hospitalization the improvement in NIHSS scale was 
observed.
In our study, we also assessed the laboratory re-
sults of patients before the stroke incident, what 
indicated, that more than a half of them had elevat-
ed level of CRP, and almost 1/3 of them — WBC 
above the normal range and there was a significant 
correlation between CRP and NIHSS on admission. 
The researchers indicate that the level of CRP taken 
within 12–24h of the onset of stroke is an indepen-
dent predictor of unfavourable functional outcome 
of patients in the assessment after one year [21]. 
Researchers underline that CRP is both a risk and 
a prognostic factor for ischemic stroke and coronary 
events — mean CRP was significantly higher in 
stroke patients especially if stroke was caused by car-
dioembolism (3-fold increase in risk) and atheroscle-
rosis of large arteries (2-fold increase in risk) [23]. It 
could be concluded that CRP may be a marker that 
could initiate basic preventive strategies in the future.
Lastly, it is worth mentioning that the level of 
CRP was significantly higher in the group of pa-
tients who did not improve the clinical condition, 
but our study also showed that their post-stroke 
changes in the brain were greater. Other researchers 
also indicate that the infarct volume is significantly 
positively correlated with serum CRP level [24]. We 
have noticed that inflammation was correlated with 
the magnitude of stroke lesion in CT at discharge, 
what may suggest that the severity of inflammation 
at admission indicates the number of cells that have 
already been damaged. Recent evidence suggests that 
blood biomarkers may be equally effective in predict-
ing functional outcome as image biomarkers [21].
Conclusions
In conclusion we would like to underscore that hy-
pertensive women experience first-ever stroke at old-
er age as compared to men, however, the volume of 
brain ischemia at admission is greater in women than 
in men.
The clinical state of the patients assessed in NI-
HSS scale shows association with serum inflamma-
tory markers which are coupled with. 
The evident association between the volume of 
stroke lesion in CT and severity of inflammatory 
process.
Despite no changes in the volume of ischemic 
brain areas the improvement in NIHSS scale was 
observed. The easily available serum inflammatory 
marker seems to predict prognosis prior to brain 
CT-changes.
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